Director, regulatory affairs cmc europe
ZugCytokinetics
...activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. As a leader in muscle biology and the mechanics of muscle performance, the company is developing small molecule drug candidates specifically engineered to impact [...]
Kategorie Marketing